147 related articles for article (PubMed ID: 2313287)
1. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
O'Riordan C; Phillips OM; Williams DC
J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
[TBL] [Abstract][Full Text] [Related]
2. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
[TBL] [Abstract][Full Text] [Related]
3. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
Plenge P; Mellerup ET; Laursen H
Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
[TBL] [Abstract][Full Text] [Related]
4. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant binding to the porcine and human platelet serotonin transporters.
Humphreys CJ; Levin J; Rudnick G
Mol Pharmacol; 1988 Jun; 33(6):657-63. PubMed ID: 3380080
[TBL] [Abstract][Full Text] [Related]
6. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
Marcusson JO; Ross SB
Psychopharmacology (Berl); 1990; 102(2):145-55. PubMed ID: 2274599
[TBL] [Abstract][Full Text] [Related]
7. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
Segonzac A; Schoemaker H; Tateishi T; Langer SZ
J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
[TBL] [Abstract][Full Text] [Related]
8. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
Phillips OM; Wood KM; Williams DC
J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
[TBL] [Abstract][Full Text] [Related]
9. Solubilization and assay of [3H]imipramine binding sites from human platelets.
Davis A; Morris J; Tang SW
Eur J Pharmacol; 1983 Jan; 86(3-4):353-9. PubMed ID: 6299755
[TBL] [Abstract][Full Text] [Related]
10. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.
Wennogle LP; Meyerson LR
Life Sci; 1985 Apr; 36(16):1541-50. PubMed ID: 3982224
[TBL] [Abstract][Full Text] [Related]
11. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
Marcusson JO; Bäckström IT; Ross SB
Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
[TBL] [Abstract][Full Text] [Related]
12. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
Wood MD; Broadhurst AM; Wyllie MG
Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
[TBL] [Abstract][Full Text] [Related]
13. [3H]citalopram binding to brain and platelet membranes of human and rat.
Plenge P; Mellerup ET
J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
[TBL] [Abstract][Full Text] [Related]
14. Studies on the serotonin transporter in platelets.
Langer SZ; Galzin AM
Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
[TBL] [Abstract][Full Text] [Related]
15. Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
Meyerson LR; Ieni JR; Wennogle LP
J Neurochem; 1987 Feb; 48(2):560-5. PubMed ID: 3491878
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
Phillips OM; Wood KM; Williams DC
Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
[TBL] [Abstract][Full Text] [Related]
17. Changes induced by corticosterone and adrenalectomy in synaptosomal and platelet uptake and binding of 5-HT. The relationship to [3H]imipramine binding.
Lee PH; Chan MY
Neuropharmacology; 1985 Nov; 24(11):1043-50. PubMed ID: 4080103
[TBL] [Abstract][Full Text] [Related]
18. [The nature of the interactions of imipramine and serotonin with human lymphocytes].
Lesnichuk SA; Katukov VIu; Porodenko NV
Eksp Klin Farmakol; 1997; 60(6):40-3. PubMed ID: 9460597
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
Davis A; Morris JM; Tang SW
Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
[TBL] [Abstract][Full Text] [Related]
20. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
Segonzac A; Schoemaker H; Langer SZ
J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
